Skip to content

?Study of Methyl Prednisolone effects on fat emboli in the patients with fractures

Study of Methyl Prednisolone preventive effects in Fat Embolism Syndrome on Patients with Fracture of Long Bones

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2013101311898N6
Enrollment
94
Registered
2014-12-24
Start date
2014-12-03
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fat Embolism. Fat embolism (traumatic)

Interventions

Intervention 1: intraveinously injection of Methyl prednisolone with the dosage of 10 mg/kg every 4 hours during 72 h of addmission. Intervention 2: intraveinously injection of placebo(normal
Treatment - Drugs
Placebo
intraveinously injection of Methyl prednisolone with the dosage of 10 mg/kg every 4 hours during 72 h of addmission
intraveinously injection of placebo(normal salin) with the dosage of 10 mg/kg every 4 hours during 72 h of addmission

Sponsors

Research and Technology Department of Guilan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criteria: Patiens with closed fractures of femor or tibia that refers to poursina hospital Exclusion criteria: patients with skull,chest,lungs,pelvic,diaphragm,urogential injuries and pathologic fracture,pregnant women, history of cardiac and lung disease or a history of corticosteroid treatment will not be included in

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Pco2>55mmhg. Timepoint: first visit,12h.24h,72h after admission. Method of measurement: mmhg, lab tests.;Po235 per minute. Timepoint: first visit,12h.24h,72h after admission. Method of measurement: clinical examination.;Dyspnea, Tachypnea. Timepoint: first visit,12h.24h,72h after admission. Method of measurement: clinical examination.

Secondary

MeasureTime frame
Acidotic Arterial blood PH. Timepoint: first visit, 12h,24,72 h after admission. Method of measurement: Lab test(ABG).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Sadeq Mousavi

Research and Technology Department, Guilan University of Medical Sciences

arman.mousavi1989@gmail.com+98 13 3355 2241

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026